KLT Pharmaceutical

Jiangsu KLT Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and large-scale manufacturing of peptide-based therapeutics. The company operates advanced, GMP-compliant facilities dedicated to the production of high-purity peptide active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio addresses critical needs in metabolic diseases, oncology, and immunology, featuring established products such as Liraglutide and Teriparatide. In addition to its own pharmaceutical pipeline, KLT provides comprehensive CDMO services, leveraging proprietary solid-phase and liquid-phase synthesis platforms to support global drug development partners. The company is strategically located in Lianyungang, a major pharmaceutical industrial hub, facilitating its role as a key supplier in the international peptide market.